Topical 5FU

DRUG2 trials

Sponsors

Massachusetts General Hospital

Conditions

Actinic KeratosesCutaneous Squamous Cell CarcinomaImmunotherapyOrgan Transplant RecipientsSkin Cancer

Phase 2

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

WithdrawnNCT04329221

Massachusetts General HospitalActinic Keratoses, Cutaneous Squamous Cell Carcinoma, Immunotherapy +2

Start: 2026-01-01End: 2030-01-31Updated: 2025-05-07

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

WithdrawnNCT04642287

Massachusetts General HospitalActinic Keratoses, Cutaneous Squamous Cell Carcinoma, Immunotherapy +2

Start: 2026-01-31End: 2030-01-31Updated: 2025-05-07